Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
688317
vs
S
Shanghai Composite
688317
Over the past 12 months, Shanghai ZJ Bio-Tech Co Ltd has underperformed Shanghai Composite, delivering a return of -17% compared to Shanghai Composite's 2% drop.
Stocks Performance
688317 vs Shanghai Composite
Performance Gap
688317 vs Shanghai Composite
Performance By Year
688317 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Shanghai ZJ Bio-Tech Co Ltd
Glance View
Shanghai ZJ Bio-Tech makes in vitro diagnostic products used to screen and test human blood and tissue samples. Its core products are test kits, reagents, and supporting instruments for medical labs, hospitals, and blood centers. These products help clinicians and blood banks check for infections and other markers before treatment or transfusion. The company sells mainly to hospitals, disease-control labs, and blood collection and testing institutions. It earns money by selling disposable reagents and related testing systems, often with recurring demand as customers keep using the same platforms and need fresh test consumables. That makes the business more like a medical supply and testing tools company than a one-off equipment maker. What sets its business apart is its role in the blood-testing value chain. Instead of treating patients directly, it supplies the tools that other healthcare providers use to make testing faster, safer, and more standardized. That gives it a stable place in a regulated part of healthcare where product quality, reliability, and compliance matter a lot.